Design of a Randomised Controlled Trial (RCT) on the effectiveness of a Dutch patient advocacy case management intervention among severely disabled Multiple Sclerosis patients

Table 2 Measures

Variable	Measure	Applied to	T0	T1	Cont
Demographics	Usual questions	Patient and Caregiver	X
Medical history	Usual questions	Patient	X
Quality of Life	WHOQOL-BREF	Patient and Caregiver	X	X
	MSIP	Patient	X	X
	IPAQ BDI-II	Patient and Caregiver	X	X
	BDI-II	Patient and Caregiver	X	X
Quality of Care	CSQ	Patient and Caregiver	X	X
	Care plan/Medical letter	-			X
	EQ-5D	Patient and Caregiver	X	X
Caregiver burden	General Inventory	Caregiver	X	-
	CSI	Caregiver	X	X
Costs	Care plan/Medical letter	-			X
	Costs booklet	Patient			X

T0 = at baseline after before randomization. T1 = 15 months after finishing the intervention. Cont. = continuous. WHOQOL-BREF = World Health Organization Quality of Life, abbreviated version; MSIP = Multiple Sclerosis Impact Profile; IPAQ = Impact on Participation and Autonomy Questionnaire; BDI-II = Beck Depression Inventory-II; CSQ = Consumer Satisfaction Questionnaire; EQ-5D = Health related Quality of Life Index; CSI = Caregiver Strain Index

ISSN: 1472-6963